Understanding sbs

SBS is a complex, chronic condition, and affected patients have unique needs^2,3

Learn more about how
SBS affects patients

Life with sbs

While SBS management has improved, many patients face significant challenges that impact their daily lives^4,5

Discover how SBS creates
challenges for patients

our commitment

Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.

REFERENCES —

1. Jeppesen PB. Spectrum of short bowel syndrome in adults: intestinal insufficiency to intestinal failure. JPEN J Parenter Enteral Nutr. 2014;38(suppl 1):S8-S13. doi:10.1177/0148607114520994

2. Belcher E, Mercer D, Raphael BP, Salinas GD, Stacy S, Tappenden KA. Management of short-bowel syndrome: a survey of unmet educational needs among healthcare providers. JPEN J Parenter Enteral Nutr. 2022;46(8): 1839-1846. doi:10.1002/jpen.2388

3. Pironi L, Arends J, Baxter J, et al. ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults. Clin Nutr. 2015;34(2):171-180. doi:10.1016/j.clnu.2014.08.017

4. Parrish CR, DiBaise JK. Managing the adult patient with short bowel syndrome. Gastroenterol Hepatol. 2017;13(10):600-608.

5. Data on file. SBS patient insights program: digital ethnography study report. Trinity, LLC. August 16, 2023.

This site is intended for US healthcare professionals only.

COM-US-NON-0018 v2 01/25